ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Epstein-Barr virus (EBV)"

  • 2017 American Transplant Congress

    Presence of Anellovirus Nucleic Acid Sequences in Involved Tissue Is Associated with Worse Patient Survival in Post-Transplant Lymphoproliferative Disorder.

    V. Dharnidharka, R. Chen, M. Ruzinova, P. Parameswaran, H. O'Gorman, K. Wylie, G. Storch.

    Washington University in St Louis School of Medicine, St. Louis

    Introduction: PTLD remain a feared complication of organ and tissue transplant, with high morbidity and mortality. While 50-80% of cases are strongly associated with Epstein-Barr…
  • 2017 American Transplant Congress

    Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

    B.-H. Shin,1 S. Ge,1 J. Mirocha,2 D. Thomas,1 E. Rodriguez,1 C. Chao,1 O. Galera,1 A. Vo,1 J. Choi,1 A. Peng,1 J. Kahwaji,1 S. Jordan,1 M. Toyoda.1

    1Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Biostatistics Core, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA

    Background: PTLD is a serious complication in KTx pts and is usually associated with EBV infection. Recent studies showed that rituximab treatment prior to Tx…
  • 2017 American Transplant Congress

    Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.

    E. Engels, P. Mahale, M. Shiels.

    National Cancer Institute, Bethesda, MD

    Background: Risk of primary central nervous system lymphoma (PCNSL) is greatly increased in immunosuppressed HIV-infected people. Case series describe PCNSL in solid organ transplant (SOT)…
  • 2017 American Transplant Congress

    Does EBV Viremia at Time of Transplant Have a Negative Impact on Transplant Outcomes?

    P. Verghese, H. Balfour, D. Schmeling, J. Grimm, S. Chinnakotla, A. Matas.

    University of Minnesota, Minneapolis

    Being EBV antibody (Ab) positive at the time of transplant increases the risk of post-transplant lymphoproliferative disorder (PTLD) and is a significant threat to patient…
  • 2016 American Transplant Congress

    Initial Evaluation of Use of NAT in Assignment of CMV and EBV Infection Status in Children Awaiting Solid Organ Transplant.

    C. Burton, Y. Tong, J. Preiksaitis.

    Medicine, University of Alberta, Edmonton, Canada.

    Purpose: The presence of passive antibodies, transfusion-acquired or maternal in infants, can make serologic determination of pre-transplant CMV and EBV status in children unreliable. We…
  • 2016 American Transplant Congress

    NKG2A-Expressing Natural Killer Cells Dominate the Response to Latent Epstein-Barr Virus Infection.

    O. Hatton,1 D. Strauss-Albee,2 S. Krams,1 C. Blish,2 O. Martinez.1

    1Surgery, Stanford University School of Medicine, Stanford, CA; 2Medicine, Stanford Univerity School of Medicine, Stanford, CA.

    Introduction: EBV infection elicits a robust host immune response in healthy, immunocompetant individuals. EBV immunity is essential for preventing EBV­-associated lymphomas in transplant recipients, including…
  • 2016 American Transplant Congress

    Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

    S. Florman,1 J. Medina Pestana,2 M. del C Rial,3 L. Rostaing,4 D. Kuypers,5 A. Matas,6 T. Wekerle,7 J. Grinyó,8 U. Meier-Kriesche,9 M. Polinsky,9 H. Zhao,9 A. Durrbach.10

    1Mount Sinai Med Ctr, New York; 2Hosp do Rim, Sao Paulo, Brazil; 3Instituto de Nefrologia, Buenos Aires, Argentina; 4Univ Hosp, Toulouse, France; 5Univ Hosp Leuven, Leuven, Belgium; 6Univ of Minnesota, Minneaopolis; 7Med Univ of Vienna, Vienna, Austria; 8Univ Hosp Bellvitge, Barcelona, Spain; 9BMS, Lawrenceville; 10Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France.

    At 7 yrs post transplant in BENEFIT-EXT (NCT00114777), bela-treated pts had similar graft survival and improved renal function vs CsA-treated pts. Bela is indicated for…
  • 2016 American Transplant Congress

    Identification of MicroRNAs in EBV+ B Cell Lymphomas and Secreted Exosomes.

    V. Kaul, A. Harris-Arnold, C. Esquivel, O. Martinez, S. Krams.

    Division of Abdominal Transplantation, Dept. of Surgery, Stanford University, Stanford.

    Introduction Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation commonly associated with Epstein Barr virus (EBV) infection. EBV viral loads are…
  • 2016 American Transplant Congress

    Examining the Risk for Post-Transplant Viral Infections and Lymphoproliferative Disorder (PTLD) in Kidney Transplant Patients (Pts) Receiving Calcineurin Inhibitor-Based Immunosuppression (CNI-IS) Compared to Belatacept (CTLA4Ig).

    B. Shin, J. Choi, J. Kahwaji, S. Ge, D. Thomas, A. Vo, O. Galera, R. Villicana, A. Peng, S. Jordan, M. Toyoda.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction: CTLA4Ig is a novel IS agent that acts through costimulatory blockade of T-cells and obviates the need for CNI. Despite benefits in improving renal…
  • 2016 American Transplant Congress

    Integrative, Multi-Cohort Analysis of Epstein-Barr Virus (EBV)-Positive and Negative Tumor Samples to Identify Gene-Signatures Associated with EBV Oncogenesis.

    E. Maloney, E. Bongen, F. Vallania, N. Kotecha, P. Khatri, O. Martinez.

    Stanford School of Medicine, Stanford, CA.

    EBV is linked to a variety of lymphoid and epithelial malignancies. In transplant recipients EBV is associated with the development of B cell lymphomas in…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences